Notify me when Foresite Capital Management IV, LLC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | 6 | $182,608,465 | +$34,369,493 | -$45,922,973 | -$11,553,480 | PHVS, CYTK, MAZE, LYEL, XENE | 13F-HR | 14 Nov 2025, 16:07 |
| Q2 2025 | 6 | $123,796,408 | +$12,083,527 | -$10,314,453 | +$1,769,074 | PHVS, MAZE, Lyell Immunopharma, Inc., XENE, KURA | 13F-HR | 12 Aug 2025, 16:01 |
| Q1 2025 | 5 | $111,069,074 | +$27,585,071 | -$4,059,000 | +$23,526,071 | PHVS, MAZE, LYEL, KURA, RLAY | 13F-HR | 15 May 2025, 16:02 |
| Q4 2024 | 4 | $108,796,521 | $0 | -$17,915,646 | -$17,915,646 | PHVS, KURA, LYEL, RLAY | 13F-HR | 14 Feb 2025, 14:28 |
| Q3 2024 | 5 | $153,008,970 | +$9,006,580 | $0 | +$9,006,580 | PHVS, KURA, SNDX, LYEL, RLAY | 13F-HR | 14 Nov 2024, 14:18 |
| Q2 2024 | 4 | $148,849,864 | +$4,794,226 | -$25,726,570 | -$20,932,344 | PHVS, KURA, SNDX, LYEL | 13F-HR | 13 Aug 2024, 14:27 |
| Q1 2024 | 5 | $197,913,329 | $0 | $0 | $0 | PHVS, KURA, KNTE, SNDX, LYEL | 13F-HR | 15 May 2024, 12:28 |
| Q4 2023 | 5 | $197,872,800 | +$8,285,746 | -$46,772,642 | -$38,486,896 | PHVS, KURA, KNTE, SNDX, LYEL | 13F-HR | 13 Feb 2024, 14:04 |
| Q3 2023 | 7 | $180,036,899 | -$1,345,325 | -$1,345,325 | PHVS, CBAY, ACRS, KURA, KNTE | 13F-HR | 13 Nov 2023, 16:43 | |
| Q2 2023 | 7 | $203,401,092 | +$7,517,373 | -$954,000 | +$6,563,373 | PHVS, LYEL, KNTE, ACRS, KURA | 13F-HR | 11 Aug 2023, 06:52 |
| Q1 2023 | 8 | $192,724,463 | $0 | KNTE, PHVS, LYEL, ACRS, KURA | 13F-HR | 12 May 2023, 09:17 | ||
| Q4 2022 | 8 | $234,124,533 | +$4,708,250 | +$4,708,250 | KNTE, ACRS, PHVS, LYEL, KURA | 13F-HR | 13 Feb 2023, 15:49 | |
| Q3 2022 | 8 | $310,955,000 | +$16,580,976 | -$24,058,387 | -$7,477,411 | KNTE, LYEL, ACRS, KURA, PHVS | 13F-HR | 14 Nov 2022, 08:28 |
| Q2 2022 | 8 | $371,386,000 | -$12,328,207 | -$12,328,207 | KNTE, LYEL, PHVS, ACRS, KURA | 13F-HR | 12 Aug 2022, 09:25 | |
| Q1 2022 | 9 | $357,448,000 | -$15,860,586 | -$15,860,586 | KNTE, LYEL, PHVS, ACRS, KURA | 13F-HR | 13 May 2022, 09:07 | |
| Q4 2021 | 9 | $486,015,000 | $0 | KNTE, LYEL, ACRS, PHVS, QSI | 13F-HR | 11 Feb 2022, 14:01 | ||
| Q3 2021 | 12 | $679,115,000 | +$11,882,026 | -$31,145,985 | -$19,263,959 | KNTE, LYEL, ACRS, PHVS, QSI | 13F-HR | 12 Nov 2021, 09:56 |
| Q2 2021 | 13 | $739,796,000 | +$272,553,596 | -$213,618,005 | +$58,935,591 | KNTE, LYEL, PHVS, ACRS, QSI | 13F-HR | 13 Aug 2021, 18:21 |
| Q1 2021 | 13 | $834,839,000 | +$157,518,388 | -$113,861,800 | +$43,656,588 | KNTE, PHVS, ACRS, KROS, RLAY | 13F-HR | 14 May 2021, 19:19 |
| Q4 2020 | 13 | $920,621,000 | +$445,616,739 | -$4,917,242 | +$440,699,497 | KNTE, KROS, RLAY, ALXO, NRIX | 13F-HR | 16 Feb 2021, 07:48 |
| Q3 2020 | 15 | $443,450,000 | +$228,868,268 | -$15,898,018 | +$212,970,250 | RLAY, NRIX, KROS, KURA, ALXO | 13F-HR | 13 Nov 2020, 09:55 |
| Q2 2020 | 12 | $205,283,000 | +$128,874,520 | -$30,914,776 | +$97,959,744 | KROS, CYTK, KURA, FULC, PCVX | 13F-HR | 13 Aug 2020, 10:04 |
| Q1 2020 | 11 | $81,136,000 | +$11,983,429 | -$40,706,811 | -$28,723,382 | CYTK, MYOK, FULC, INSM, BHVNXXXX | Restatement | 28 May 2020, 12:58 |
| Q4 2019 | 14 | $231,764,000 | +$23,290,213 | -$56,686,698 | -$33,396,485 | AERI, MDCO, INSM, CYTK, FULC | 13F-HR | 14 Feb 2020, 14:31 |
| Q3 2019 | 19 | $309,434,000 | +$49,706,625 | -$16,541,357 | +$33,165,268 | TPTX, AERI, INSM, MDCO, ASND | 13F-HR | 13 Nov 2019, 08:05 |
| Q2 2019 | 22 | $353,792,000 | +$128,146,567 | -$23,044,644 | +$105,101,923 | TPTX, INSM, ASND, ALEC, CYTK | 13F-HR | 13 Aug 2019, 10:02 |
| Q1 2019 | 15 | $267,578,000 | +$23,467,973 | -$41,528,313 | -$18,060,340 | INSM, CBAY, ASND, BHVNXXXX, OPTN | 13F-HR | 14 May 2019, 10:47 |
| Q4 2018 | 18 | $217,868,000 | +$40,687,866 | -$15,890,403 | +$24,797,463 | BHVNXXXX, INSM, MYOK, CBAY, IMMU | 13F-HR | 13 Feb 2019, 16:12 |
| Q3 2018 | 21 | $305,020,000 | +$47,213,084 | -$8,219,355 | +$38,993,729 | INSM, MYOK, BHVNXXXX, IMMU, ABUS | 13F-HR | 13 Nov 2018, 13:33 |
| Q2 2018 | 17 | $293,368,000 | +$65,292,212 | -$41,540,097 | +$23,752,115 | INSM, BHVNXXXX, IMMU, MYOK, CBAY | 13F-HR | 14 Aug 2018, 16:03 |
| Q1 2018 | 18 | $241,186,000 | +$92,791,055 | -$7,145,696 | +$85,645,359 | INSM, ASND, CBAY, BHVNXXXX, MYOK | 13F-HR | 15 May 2018, 09:43 |
| Q4 2017 | 13 | $142,664,000 | $0 | INSM, ASND, CBAY, IMMU, MYOK | 13F-HR | 13 Feb 2018, 12:14 |